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Abstract
Introduction:  There  is  inconclusive  evidence  whether  osteoporosis  increases  risk  of  hearing  loss
in current  literature.
Objective:  We  conducted  this  meta-analysis  to  determine  whether  there  is  an  association
between  hearing  loss  and  osteoporosis.
Methods:  This  systematic  review  and  meta-analysis  was  conducted  from  the  studies  in  MEDLINE,
EMBASE, and  LILACS.  Osteoporosis  was  deﬁned  as  having  a  bone  mineral  density  (BMD)  with  a
T-score of  less  than  −2.5  standard  deviation.  The  outcome  was  hearing  loss  as  assessed  by
audiometry  or  self-reported  assessment.  Random-effects  model  and  pooled  hazard  ratio,  risk
ratio, or  odds  ratio  (OR)  of  hearing  loss  with  95%  conﬁdence  intervals  (CI)  were  compared
between normal  BMD  and  low  BMD  or  osteoporosis.
Results:  A  total  of  16  articles  underwent  full-length  review.  Overall,  there  was  a  statistically
signiﬁcant  increased  odds  of  hearing  loss  in  the  low  BMD  or  osteoporosis  group  with  OR  of
1.20 (95%  CI  1.01--1.42,  p  =  0.04,  I2 =  82%,  Pheterogeneity =  0.01).  However,  the  study  from  Helzner
et al.  reported  signiﬁcantly  increase  odds  of  hearing  loss  in  the  low  BMD  in  particular  area  and
population included  femoral  neck  of  black  men  1.37  (95%  CI  1.07--1.76,  p  =  0.01)  and  total  hip
of black  men  1.36  (95%  CI  1.05--1.76,  p  =  0.02).
Conclusion:  Our  study  proposed  the  ﬁrst  meta-analysis  that  demonstrated  a  probable  associa-
tion between  hearing  loss  and  BMD.  Osteoporosis  could  be  a  risk  factor  in  hearing  loss  and  might
play an  important  role  in  age-related  hearing  loss.
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PALAVRAS  CHAVE
Osteoporose;
Perda  auditiva;
Metanálise
Associac¸ão  signiﬁcativa  entre  osteoporose  e  perda  auditiva:  uma  revisão  sistemática
e  metanálise
Resumo
Introduc¸ão:  Há  evidências  inconclusivas  sobre  se  a  osteoporose  aumenta  o  risco  de  perda  audi-
tiva na  literatura  atual.
Objetivo:  Realizamos  esta  metanálise  para  determinar  se  existe  uma  associac¸ão  entre  perda
auditiva e  osteoporose.
Método:  revisão  sistemática  e  metanálise  foram  realizadas  a  partir  dos  estudos  em  MEDLINE,
EMBASE  e  Lilacs.  A  osteoporose  foi  deﬁnida  como  tendo  uma  densidade  mineral  óssea  (DMO)  com
um escore  T  de  menos  que  -2,5  DP.  O  desfecho  foi  a  perda  auditiva,  avaliada  por  audiometria
ou avaliac¸ão  autorrelatada.  O  modelo  de  efeitos  aleatórios  e  agrupados  HR,  RR  ou  OR  de  perda
auditiva com  Intervalos  de  Conﬁanc¸a (IC)  de  95%  foram  comparados  entre  DMO  normal  e  DMO
baixa ou  osteoporose.
Resultados:  Um  total  de  16  artigos  foram  submetidos  a  revisão  completa.  Em  geral,  houve
aumento estatisticamente  signiﬁcativo  da  probabilidade  de  perda  auditiva  no  grupo  de  baixa
DMO ou  no  grupo  de  osteoporose  com  OR  de  1,20  (IC  95%  1,01-1,42,  p  =  0,04,  p  =  82%,
Pheterogeneidade =  0,01).  No  entanto,  o  estudo  de  Helzner  et  al.  relatou  aumento  signiﬁcativo  da
probabilidade  de  perda  auditiva  na  DMO  baixa,  em  determinada  área  e  populac¸ão  que  incluiu
colo femoral  de  homens  negros  1,37  (IC  95%  1,07-1,76,  p  =  0,01)  e  quadril  total  de  homens
negros 1,36  (IC  95%  1,05-1,76,  p  =  0,02).
Conclusão:  Nosso  estudo  propôs  a  primeira  metanálise  que  demonstrou  uma  provável  associac¸ão
entre perda  auditiva  e  DMO.  A  osteoporose  pode  ser  um  fator  de  risco  para  perda  auditiva  e
pode desempenhar  um  papel  importante  na  perda  de  audic¸ão  relacionada  com  a  idade.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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were  described;  (4)  clear  diagnostic  criteria  for  osteoporo-ntroduction
earing  loss  is  a  common  chronic  condition  of  a  disability
stimated  at  24.9  million  people  worldwide.  It  was  reported
y  The  World  Health  Organization  as  one  of  the  leading
auses  of  years  lived  with  disability.1 The  estimated  preva-
ence  of  hearing  loss  was  30%  in  the  population  over  65  years
ld  and  50%  in  the  population  over  75  years  old.2,3 Moreover,
earing  loss  is  also  associated  with  decreasing  quality  of  life
nd  functional  outcomes  including  social  isolation,  depres-
ion,  safety  issues,  mobility  limitations,  reduced  income  and
mployment  opportunities.4--7 Risk  factors  inﬂuence  to  the
egree  and  rate  of  deterioration  of  hearing  loss  include
ging,  genetic  susceptibility,  ototoxic  medication  exposure,
tological  disorders,  smoking,  and  occupational  and  leisure
oise  exposure.6,8--10
Osteoporosis  has  also  been  identiﬁed  in  some  studies  as
 risk  factor  of  hearing  loss.  The  underlying  mechanism
f  hearing  loss  in  osteoporosis  is  complex  and  undeter-
ined.  Some  studies  purposed  that  a  possible  underlying
echanism  is  systemic  demineralization  of  the  skeletal
ystem  in  osteoporosis  includes  temporal  bone,  which  con-
ains  the  cochlea  capsule  and  the  conductive  system.11--13
owever,  there  were  controversies  and  inconsistent  results
rom  other  studies  that  showed  non-signiﬁcant  association
etween  osteoporosis  and  hearing  loss.  The  accuracy  of  the
esults  was  limited  due  to  the  sample  sizes  of  the  study
opulations.2 Therefore,  we  conducted  this  meta-analysis  to
etermine  whether  there  is  an  association  between  hearing
oss  and  low  bone  mass  or  osteoporosis.
s
laterials and methods
his  systematic  review  and  meta-analysis  was  conducted
nd  reported  according  to  the  Meta-analysis  Of  Observa-
ional  Studies  in  Epidemiology  statement14 and  was  regis-
ered  in  PROSPERO  (registration  number:  CRD42015024987).
earch  strategy
wo  authors  (AS,  SU)  independently  searched  published
tudies  indexed  in  the  MEDLINE,  EMBASE,  and  LILACS  (Lit-
ratura  Latino  Americana  em  Ciências  da  Saúde)  from
heir  date  of  inception  to  November  2015.  References  of
ll  selected  studies  were  also  examined.  The  following
ain  search  terms  were  used:  osteoporosis,  osteopenia,
one  density,  bone  mass,  bone  loss,  hearing  loss,  audiom-
try,  otoacoustic.  The  full  search  strategy  was  detailed  in
ppendix  1.
nclusion  and  exclusion  criteria
rticles  were  considered  eligible  for  inclusion  if  the  follow-
ng  criteria  were  met:  (1)  published  observational  studies
ncluding  cross-sectional,  cohort,  and  case--control  studies;
2)  study  in  adults  age  18  years  or  older;  (3)  clear  methods
f  assessment  of  bone  mineral  density  and  hearing  statusis  and  hearing  loss  were  reported;  and  (5)  association  of
ow  BMD  or  osteoporosis  and  hearing  loss  was  reported  as
 IN+Model
h
o
b
o
i
w
i
W
t
s
e
s
I
s
g
E
R
D
T
w
studies  (23  articles),  did  not  have  BMD  data  (12  articles),
did  not  have  hearing  loss  data  (6  articles),  or  did  not  mea-
sure  association  between  BMD  and  hearing  loss  (26  articles).
A  total  of  16  articles  underwent  full-length  review.  Data
Records identified through
database searching (n=127)
Medline=41
Embase=42
Records after duplicates removed
(n=83)
Records screened
(n=83)
Full-text articles assessed
for eligibility
Studies included in
qualitative synthesis
Records excluded
(n=67)
Full-text articles excluded,
with reasons
(n=9)
Data not available (n=2)
Non-observational study
(n=1)
No association assessment
(n=2)
No outcome (n=2)
Studies included in
quantitative synthesisARTICLE
Osteoporosis  and  hearing  loss  
either  adjusted  or  unadjusted  hazard  ratios  (HRs),  rela-
tive  risks  (RRs),  or  odds  ratios  (ORs)  with  associated  95%
conﬁdence  intervals  (CIs),  or  hearing  sensitivity  in  decibels.
Exclusion  criteria  were  (1)  reviews,  case  reports,  abstracts,
and  unpublished  studies,  (2)  studies  without  speciﬁc  sam-
ple  origins,  (3)  data  in  the  study  was  not  presented  clearly
enough,  and  (4)  participants  with  known  otosclerosis.
Osteoporosis  was  deﬁned  as  having  a  bone  mineral  den-
sity  (BMD)  with  a  T-score  of  less  than  −2.5  SD  as  measured
by  dual-energy  X-ray  absorptiometry  or  other  standard  tech-
nique  at  anatomical  bone  sites  including  lumbar  spine,
femoral  neck,  and  total  hip.  The  main  outcome  of  this  study
was  hearing  loss  as  assessed  by  audiometry  or  self-reported
assessment.  We  used  the  deﬁnition  of  hearing  loss  (conduc-
tive,  sensorineural,  or  mixed)  as  described  by  each  study.
Data  extraction
Two  authors  (AS  and  SU)  independently  reviewed  titles  and
abstracts  of  all  citations  that  were  identiﬁed.  After  all
abstracts  were  reviewed,  data  comparisons  between  the
two  investigators  were  conducted  to  ensure  completeness
and  reliability.  The  inclusion  criteria  were  independently
applied  to  all  identiﬁed  studies.  Differing  decisions  were
resolved  by  consensus.
Full-text  versions  of  potentially  relevant  papers  iden-
tiﬁed  in  the  initial  screening  were  retrieved.  If  multiple
articles  from  the  same  study  were  found,  only  the  article
with  the  most  complete  data  was  included.  Data  con-
cerning  study  design,  participant  characteristics,  source  of
data,  comorbidities,  methods  of  assessing  BMD  and  hearing
impairment,  outcome  assessment,  and  factors  adjusted  in
multivariable  analysis  were  independently  extracted.
Assessment  of  quality
A  subjective  assessment  of  methodological  quality  for  obser-
vational  studies  was  evaluated  by  two  authors  (AS  and  SU)
using  the  Newcastle--Ottawa  Scale  (NOS).  The  NOS  is  a  qual-
ity  assessment  tool  for  non-randomized  studies.  The  NOS
includes  eight  items,  categorized  into  three  dimensions  of
selection,  comparability,  and  outcome.  For  each  dimension,
a  list  of  response  options  is  provided.  Scoring  is  based  on  a
semi-quantitative  assessment  of  study  quality.  The  highest
quality  studies  are  scored  a  maximum  of  one  point  for  each
item.  However,  there  is  an  exception  of  the  item  related
to  comparability  that  allows  the  assignment  of  two  points.
The  range  of  NOS  is  between  zero  up  to  nine  points.15 A
total  score  of  3  or  less  was  considered  poor,  4--6  was  con-
sidered  moderate,  and  7--9  was  deemed  high  quality.  We
excluded  studies  from  our  meta-analysis  if  they  had  poor
quality.  Discrepant  opinions  between  authors  were  resolved
by  consensus.
Statistical  analysisWe  performed  meta-analysis  of  the  included  studies  using
Comprehensive  Meta-Analysis  3.3  software  from  Biostat,  Inc.
We  used  a  random-effects  model  if  there  was  high  hetero-
geneity  (I2 >  50%)  and  ﬁxed-effects  model  if  there  was  low PRESS
3
eterogeneity  (I2 <  50%).  We  calculated  pooled  HR,  RR,  or  OR
f  hearing  loss  with  95%  conﬁdence  intervals  (CI)  comparing
etween  participants  with  normal  BMD  and  with  low  BMD  or
steoporosis  at  each  anatomical  site  and  with  any  anatom-
cal  sites.  We  also  calculated  pooled  mean  difference  (MD)
ith  95%  CI  of  hearing  sensitivity  in  each  frequency  compar-
ng  between  the  normal  BMD  group  and  the  low  BMD  group.
e  excluded  studies  from  meta-analysis  and  only  presented
he  result  with  narrative  description  when  there  were  not
ufﬁcient  comparable  data  available  for  outcome  of  inter-
st.  The  heterogeneity  of  effect  size  estimates  across  these
tudies  was  quantiﬁed  using  the  Q  statistic,  its  p-value,  and
2 (p  <  0.10  was  considered  signiﬁcant).  Subgroup  analysis  by
ite  of  BMD  was  performed  to  ﬁnd  the  source  of  hetero-
eneity.  Publication  bias  was  assessed  using  funnel  plot  and
gger’s  regression  test.
esults
escription  of  included  studies
he  initial  search  yielded  83  articles  (Fig.  1);  67  articles
ere  excluded  because  they  were  not  original  observationalLetter (n=2)(meta-analysis)
Figure  1  Results  of  information  search.
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Study name
Clark, 1995
Helzner, 2005
Helzner, 2005
Helzner, 2005
Helzner, 2005
Helzner, 2005
Helzner, 2005
Helzner, 2005
Helzner, 2005
Kahveci, 2014
Mendy, 2014
Yeh, 2015
Total
Femoral neck bone density
Femoral neck-black men
Femoral neck-black women
Femoral neck-white men
Femoral neck-white women
Total hip-black men
Total hip-black women
Total hip-white men
Total hip-white women
Femur or spine
 Head
Spine, hip, or forearm
1.90
1.37
0.83
0.92
0.92
1.36
0.91
0.86
0.98
4.50
2.08
1.76
1.20
1.37
1.07
0.67
0.77
0.77
1.05
0.73
0.72
0.82
1.82
1.33
1.33
1.01
2.63
1.76
1.03
1.09
1.09
1.76
1.13
1.03
1.17
11.13
3.24
2.33
1.42
0.00
0.01
0.09
0.35
0.34
0.02
0.40
0.10
0.82
0.00
0.00
0.00
0.04
0.1 0.2
More hearing loss
in normal BMD
More hearing loss
in low BMD/osteoporosis
0.5 1 2 5 10
7.79
8.78
9.24
9.72
9.74
8.73
9.20
9.66
9.72
2.73
6.31
8.38
Subgroup Statistics for each study Odda ratio and 95% CI
Relative
weight
Odds
ratio
Lower
limit
 Upper
limit p-Value
F s  in  patients  who  had  low  bone  mineral  density  or  osteoporosis  and
c ios  and  its  95%  CI.
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Digure  2  Forest  plot  of  studies  comparing  odds  of  hearing  los
ontrol. A  diamond  data  marker  represents  the  overall  odds  rat
ere  extracted  from  eight  studies  involving  52,828  partic-
pants  who  had  bone  mineral  density  and  hearing  status
ssessed.2,12,13,16--20
Most  of  them  had  cross-sectional  design;  others  were
rospective  cohort,  retrospective  cohort,  and  case--control
tudies.  Included  studies  were  from  Turkey,  USA,  and  Korea.
hese  included  national  population-based  studies  from  two
ations.  All  participants  were  assessed  by  bone  mineral
ensity  by  standardized  methods  (dual  energy  X-ray  absorp-
iometry  or  DXA).  Sites  of  BMD  measurement  were  femur,
umbar  spine,  head,  and  methods  of  assessing  hearing
tatus  included  audiometry,  otoscopic  examination,  and
elf-reported.  The  characteristics  of  the  eight  extracted
tudies  included  in  this  review  are  outlined  in  Table  1.
uality  assessment  of  included  studies
he  quality  of  nine  cross-sectional,  three  cohort  and,  two
ase--control  studies  were  evaluated  by  NOS  (Table  1).  Total
core  ranged  from  3  to  8.  Two  studies  had  low  quality  (total
core  =  3)  and  were  exclude  from  the  meta-analysis.
eta-analysis  results
ive  studies  (2,  12,  13,  16,  20)  were  included  in  the  meta-
nalysis  of  hearing  loss.  There  was  a  statistically  signiﬁcant
ncreased  odds  of  hearing  loss  in  the  low  BMD  or  osteo-
orosis  group  with  OR  of  1.20  (95%  CI  1.01--1.42,  p  =  0.04,
2 =  82%,  Pheterogeneity =  0.01)  (Fig.  2).  The  study  from  Clark
t  al.,  Kahveci  et  al.,  Mendy  et  al.,  and  Yeh  et  al.  all  reported
igniﬁcantly  increased  odds  of  hearing  loss  in  the  low  BMD
roup  with  OR  of  1.90  (95%  CI  1.37--2.63,  p  < 0.01),  4.50  (95%
I  1.82--11.13,  p  <  0.01),  2.08  (95%  CI  1.33--3.24,  p  <  0.01),
nd  1.76  (95%  CI  1.33--2.33,  p  <  0.01),  respectively.  How-
ver,  the  study  from  Helzner  et  al.  reported  signiﬁcantly
ncreased  odds  of  hearing  loss  in  the  low  BMD  group,  in  par-
icular  the  area  and  population  included  the  femoral  neck
f  black  men  1.37  (95%  CI  1.07--1.76,  p  =  0.01)  and  total
ip  of  black  men  1.36  (95%  CI  1.05--1.76,  p  =  0.02).
S
f
ﬁLog odds ratio
Figure  3  Funnel  plot  assessing  publication  bias.
ensitivity  analysis
o  assess  the  stability  of  the  results  of  the  meta-analysis,  we
onducted  a  sensitivity  analysis  by  excluding  one  study  at  a
ime.  None  of  the  results  was  signiﬁcantly  altered,  indicating
hat  our  results  were  robust.
ublication  bias
o  investigate  potential  publication  bias,  we  examined  the
ontour-enhanced  funnel  plot  of  the  included  studies  in
ssessing  change  in  log  OR  of  hearing  loss  (Fig.  3).  The  ver-
ical  axis  represents  study  size  (standard  error)  while  the
orizontal  axis  represents  effect  size  (log  odds  ratio).  From
his  plot,  bias  is  not  present  because  there  is  symmetrical
istribution  of  studies  on  both  sides  of  the  mean.  The  Egger’s
est  was  non-signiﬁcant  (p  =  0.36).  Using  the  trim  and  ﬁll
ethods  in  the  random-effects  model,  there  was  no  differ-
nce  of  the  imputed  OR  (1.38)  and  its  95%  CI  (1.08--1.7).
iscussionince  the  association  between  bone  mass  and  hearing  loss
rom  previous  studies  are  inconsistent,  we  conducted  the
rst  meta-analysis  of  the  association  between  bone  mineral
A
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Table  1  Characteristics  of  included  studies.
Study,  year, Country  Design  Characteristics  Participants
(n)
Outcome  deﬁnition Factors  adjusted  in  multivariate
model
Age  Female  (%)
Clark  K.  et  al.,
1995
USA  Cross-sectional
descriptive  study
Women  aged
60--85  years
100  369  40  dB  HL  at  1000  and  2000  Hz  in
one ear.
40  dB  HL  at  1000  or  2000  Hz  in
both  ears.
Age  and  community  of  residence
Helzner EL
et  al.,  2004
USA  Cross-sectional
study
Women  aged  65
years  or  older
100  6474  Mild  =  hearing  at  the  more  intense
level  (40  dB  HL),  but  not  the  less
intense  level  (25  dB  HL).
Signiﬁcant  =  failing  to  hear  at  both
intensity  levels.
Age,  BMI,  estrogen  use,  sedative
use, antidepressant  use
Kim SH  et  al.,
2002
South  Korea Cross-sectional  Women  aged  50
years  or  older
100  1830  40  dB  HL  at  1000  and  2000  Hz  in
one ear.
40  dB  HL  at  1000  or  2000  Hz  in
both  ears.
Age,  bone  mineral  density,  and
serum  concentration  of  estradiol
Kahveci OK
et  al.,  2014
Turkey Case--control  study Osteoporosis,
osteopenia
patients  and
controls  was
26--85,  22--83  and
50--68  years,
respectively
100  125  Sensorineural  hearing  loss  =  bone
conduction  >  25  dB  HL  without
air-bone  gap.
Conductive  hearing  loss  =  normal
bone  conduction  threshold
average,  but  an  air-bone
gap  >  10  dB  HL.
Mendy A
et  al.,  2014
USA  Cross-sectional
survey  of  the
civilian,
noninstitutionalized
U.S.  population
Aged  40  years  and
older
No  hearing  trouble.
Little  hearing  trouble.
Signiﬁcant  hearing  trouble.
Age,  gender,  race/ethnicity,
education  level,  body  mass  index
Helzner EP
et  al.,  2005
USA  Prospective  cohort
study
Aged  70--79  47.27  2052  Hearing  loss  =  pure  tone  average
(PTA)  >  25  dB  HL  in  the  worse  ear.
Conductive  hearing  loss  =  15  dB  or
greater  or  greater  air-bone  gap  at
any  two  consecutive  frequency
tested  (0.5,  1,  2  and  4  kHz)  in  the
worse  ear.
Age,  history  of  ear  surgery,
alcohol  use,  diabetes,  smoking,
cardiovascular  disease,
cerebrovascular
disease,  mini-mental  score,
hypertension,  occupational  noise
exposure,  use  of  salicylates
Yeh MC  et  al.,
2015
Taiwan  Retrospective
cohort  study
All  Age  89.79  42,640  SSNHL  =  failing  to  hear  at  least  one
frequency  at  both  intensity  levels.
Age  group,  sex,  diabetes,
hypertension,  CAD,  chronic  kidney
disease,  income,  and  area.
Ozkiris M
et al.,  2013
Turkey  Cross-sectional  Age  range  from  50
to  55  years
100  75  Mean  values  of  air  and  bone
conduction  at  each  frequency
No  deﬁnition  of  SSNHL.
No  adjust
CAD, coronary artery disease; dB HL, decibel hearing level; SSNHL, sensorineural hearing loss.
 IN+Model
6
d
5
r
s
b
d
r
p
d
h
u
e
b
c
t
p
r
c
t
o
t
ﬁ
l
t
d
h
t
c
b
w
o
w
f
m
r
ﬁ
B
n
h
s
b
f
c
a
o
f
d
p
l
d
t
C
I
d
a
a
E
T
i
C
T
A
W
A
M
1
2
3
4
5
6
7
8
9
1
1
1
1
1
E
(
RARTICLE
 
ensity  and  hearing  loss.  According  to  our  meta-analysis  of
 studies  from  different  countries,  age  groups,  genders  and
aces,  we  found  that  a  decrease  in  BMD  or  osteoporosis  was
igniﬁcantly  associated  with  hearing  loss.
Age  related  hearing  loss  or  ‘‘presbycusis’’  is  caused
y  multifactorial  etiologies.  A  recent  study  purposed  that
emineralized  petrous  temporal  bone  in  addition  to  age-
elated  bone  mass  loss  could  be  the  cause  of  developing
resbycusis.11,21 Interestingly,  in  Paget  disease  of  the  bone,
emineralization  of  the  cochlear  bone  is  associated  with
earing  loss.  However,  the  etiology  of  the  association  is
nclear.22 In  concordance  with  demineralization  in  Paget  dis-
ase  of  the  bone,  a  study  conducted  in  otoslcerosis  patients
y  high-resolution  computed  tomographic  evaluation  of  the
ochlear  capsule  showed  decreased  BMD  at  speciﬁc  loca-
ions  on  the  cochlear  capsule.  Therefore,  decreasing  BMD
hysiologically  associates  with  hearing  loss.
The  etiology  of  Paget  disease  of  the  bone  and  otoscle-
osis  share  similar  pathogenesis  in  the  lateral  wall  of  the
ochlea,  where  the  abnormal  bone  remodeling  manipulates
he  change  in  ion  and  ﬂuid  hemostasis  in  perilymphatic  space
f  the  cochlea.23 However,  there  are  several  unique  charac-
eristics  of  the  pathologic  change  in  otosclerosis,  including
brous  thickening  and  loss  of  cochlear  blood  vessels,  spiral
igament  hyalinization  and  stria  vascularis  atrophy.24
Therefore,  imbalance  in  bone  formation  and  bone  resorp-
ion  from  osteoporosis  may  play  an  important  role  in
ysfunctional  ionic  metabolism  leading  to  sensory  neural
earing  loss.
Normally,  BMDs  at  peripheral  sites  has  a  strong  correla-
ion  with  measurements  at  hip  and  spine.  The  correlation
oefﬁcients  between  peripheral  sites  and  central  sites  is
etween  0.6  and  0.70  (25).  However,  some  populations
hose  peripheral  measurements  are  normal  could  have
steoporotic  hip  or  spine;  for  example,  the  postmenopausal
oman  with  signiﬁcant  osteoporotic  risk  factors.25 There-
ore,  different  sites  of  BMD  measurement  from  each  study
ay  not  accurately  reﬂect  total  body  BMD.  With  limited
esults  from  previous  studies,  our  study  demonstrated  the
rst  meta-analysis  of  correlation  between  hearing  loss  and
MD.  Every  study  that  was  included  in  our  meta-analysis  did
ot  report  total  body  BMD.  Nevertheless,  our  meta-analysis
as  raised  the  concern  of  hearing  loss  in  osteoporosis,
ince  our  result  is  the  strongest  evidence  of  the  association
etween  hearing  loss  and  osteoporosis  ever  reported.  There-
ore,  to  evaluate  more  evidence  of  the  association,  further
ohort  studies  of  the  association  between  total  body  BMD
nd  hearing  loss  should  be  evaluated.
The  limitations  of  our  study  include  different  hearing  loss
utcomes  and  different  sites  of  BMD  measurement  from  dif-
erent  studies.  Hearing  loss  outcomes  were  determined  in
ifferent  aspects  of  measurement  including  audiometry  and
atient  self-evaluation.  Variation  in  the  outcome  of  hearing
oss  could  potentially  alter  the  results  and  conclusion.  Since
ifferent  sites  of  BMD  measurement  may  not  be  accurate  as
otal  BMD,  the  interpretation  of  our  study  may  be  limited.onclusion
n  conclusion,  our  study  proposed  the  ﬁrst  meta-analysis  that
emonstrated  a  probable  association  between  hearing  loss PRESS
Upala  S et  al.
nd  BMD.  Osteoporosis  could  be  a  risk  factor  in  hearing  loss
nd  might  play  an  important  role  in  age-related  hearing  loss.
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ppendix 1. Search strategy
EDLINE
)  Hearing  loss.mp.  or  exp  Hearing  Loss/
) Audiometry.mp.  or  exp  Audiometry/
) Otoacoustic.mp.  [mp  =  title,  abstract,  original  title,  name  of
substance  word,  subject  heading  word,  keyword  heading
word,  protocol  supplementary  concept  word,  rare  disease
supplementary  concept  word,  unique  identiﬁer].
) Exp  Osteoporosis/or  osteoporosis.mp.
) Osteopenia.mp.
) Exp  Bone  Density/or  bone  density.mp.
) Bone  mass.mp.
) Bone  loss.mp.
) BMD.mp.
0)  Bone  mineral  density.mp.
1)  1  or  2  or  3
2)  4  or  5  or  6  or  7  or  8  or  9  or  10
3) 11  and  12
4)  limit  13  to  humans
MBASE
((’osteoporosis’/exp  or  ‘osteoporosis’  and  [embase]/lim)  or
(osteopenia  and  [embase]/lim)  or  (’bone  density’  and
[embase]/lim)  or  (’bone  mass’  and  [embase]/lim)  or  (’bone
loss’ and  [embase]/lim)  or  (bmd  and  [embase]/lim))  and
((’hearing  loss’/exp  or  ‘hearing  loss’  and  [embase]/lim)  or
(’audiometry’/exp  or  ‘audiometry’  and  [embase]/lim))  and
[humans]/lim)  and  [embase]/lim  not  [medline]/lim.
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